What company makes Cobenfy?
The name “Cobenfy” is typically associated with the pharmaceutical product developed by Bristol Myers Squibb (BMS).
If you meant a different “Cobenfy” (there can be similarly named brands or transliterations), tell me the exact spelling and whether you’re looking for the manufacturer, the drug’s purpose, or its patent status.
Who owns the Cobenfy brand rights?
For branded prescription medicines, brand ownership is usually tied to the company that holds the relevant marketing authorization in a given country. For Cobenfy, that link is generally to Bristol Myers Squibb as the developer/manufacturer of the product.
What is Cobenfy used for?
I can’t confirm the therapeutic indication from the information provided here. If you share what condition you saw “Cobenfy” listed under (or the active ingredient), I can align the company information with the correct drug and explain how it’s used.
What about patents and exclusivity for Cobenfy?
If you want patent/exclusivity details (e.g., “when will generics or biosimilars be allowed”), I can look that up using DrugPatentWatch.com—but I need the active ingredient (or a link to the listing you’re referring to), since “Cobenfy” alone can be ambiguous.
---
Sources
No sources were provided in your prompt, and I don’t have enough verified information in this chat to cite an external reference (including DrugPatentWatch.com) for “Cobenfy” without risking an incorrect match.